ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Portland, OR

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer

Diabetes trials near Portland, OR, USA:

Sotagliflozin to Slow Kidney Function Decline in Persons with Type 1 Diabetes and Diabetic Kidney Disease (SUGARNSALT)

inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...

Enrolling
Diabetic Nephropathies
Diabetes Mellitus Type 1
Drug: Placebo
Drug: Sotagliflozin

Phase 3

Alessandro Doria

Portland, Oregon, United States and 17 other locations

of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...

Enrolling
Diabetes Mellitus, Type 2
Hypercortisolism
Drug: Mifepristone 300 MG [Korlym]
Drug: Placebo for mifepristone

Phase 4

Corcept Therapeutics
Corcept Therapeutics

Portland, Oregon, United States and 35 other locations

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Portland, Oregon, United States and 42 other locations

purpose of this study is to evaluate the effectiveness and safety of the RIGHTEST Continuous Monitoring (CGM) System in adult population with diabetes...

Not yet enrolling
Type 1 Diabetes
Diabetes Mellitus
Device: RIGHTEST Continuous Glucose Monitoring System
Bionime

Portland, Oregon, United States and 12 other locations

weight in adult participants with obesity or overweight and type 2 diabetes. The study will last about 77 weeks and may include up to 22 vis...

Active, not recruiting
Type 2 Diabetes
Overweight
Drug: Orforglipron
Drug: Placebo

Phase 3

Lilly
Lilly

Portland, Oregon, United States and 138 other locations

This study will look at how much CagriSema helps participants with type 2 diabetes lower their blood sugar and body weight. CagriSema is a n...

Enrolling
Type 2 Diabetes
Drug: Semaglutide
Drug: Placebo

Phase 3

Novo Nordisk
Novo Nordisk

Portland, Oregon, United States and 48 other locations

decrease in the kidneys' ability to work properly, and type 1 diabetes.In people with type 1 diabetes, the body does not make enoug...

Enrolling
Type 1 Diabetes Mellitus
Chronic Kidney Disease
Other: Placebo
Drug: Finerenone

Phase 3

Bayer
Bayer

Portland, Oregon, United States and 84 other locations

fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...

Enrolling
Diabetic Retinopathy
Other: Placebo
Drug: Fenofibrate

Phase 3

Jaeb Center for Health Research
Jaeb Center for Health Research

Portland, Oregon, United States and 60 other locations

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high ...

Enrolling
Diabetic Retinopathy
Drug: BI 764524
Drug: Aflibercept (Eylea®) - US only

Phase 2

Boehringer Ingelheim
Boehringer Ingelheim

Portland, Oregon, United States and 23 other locations

The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Chronic Kidney Disease
Drug: Orforglipron
Drug: Insulin Glargine

Phase 3

Lilly
Lilly

Portland, Oregon, United States of America and 395 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems